Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    The Fictitious ‘Mansour Seck’

    Secondary Life Markets October 12, 2022By Jeffrey Davis
    Life settlements
    Share
    Twitter LinkedIn Email

    On July 11, 2007, according to court documents, the Mansour Seck Irrevocable Life Insurance Trust applied to MetLife Investors USA Insurance Company (the predecessor to Brighthouse Life Insurance Company) for a $5 million universal life insurance policy insuring the life of a ‘Mansour Seck’. After confirming that its procedures and guidelines were met, MetLife issued a $5 million universal life insurance policy on or around July 24, 2007.

    The life insurance application offered financial details describing a wealthy retired ambassador, a French citizen living in a three-story apartment building at 170 Academy Street in Jersey City, New Jersey. The address is in the Journal Square neighborhood, named for the Jersey Journal whose headquarters were located there from 1911 to 2013. At the time of the application, the median income in Journal Square was $32,625.

    The condition of the apartment listed on the application stands out as a clue that he may not have been living the lifestyle of a multi-millionaire French dignitary. Built in 1895, 170 Academy Street has 14 units and today rents for around $2,700 per month for a 1-bedroom.

    He could easily afford the rent. The application for Seck’s policy stated that he earned $500,000 from a pension and $1.5 million from investments each year. The 74-year-old was listed as having a net worth between $18 million and $20 million, showing he could handle premium payments as well.

    So how did a wealthy retired ambassador come to live in Journal Square? Whatever the reason, it’s clear that Seck was not your average retiree. Perhaps the ambassador was spending time at his other properties, as the application claimed; apparently, Seck owned Washington, D.C. real estate valued in excess of $4 million, real estate in Jersey City valued in excess of $1.3 million and real estate in Upper Marlboro, Maryland, valued at approximately $200,000 to $300,000.

    All seemed to proceed like any other transaction, and for the next two years the Seck Trust paid $248,711.14 in premiums. After the two-year contestability period ended, the Seck Trust sold the policy on the secondary market and in 2015 Geronta Funding purchased it in a tertiary market transaction as part of a portfolio. In 2017 Geronta notified Brighthouse of its suspicions that the insured (Seck) was a fictitious person.

    Geronta was correct.

    According to the New Jersey Office of the Attorney General, an insurance agent with the same last name and the same address — Pape Michael Seck, 170 Academy Street, Suite B23, Jersey City, New Jersey — had created fraudulent documents to supplement applications for seven multi-million-dollar life insurance policies for fictitious individuals, including the policy for Mansour Seck.

    Licensed in New York and New Jersey, he would forge documents, create false identities, and even bring on accomplices to help carry out the plan. Pape Michael Seck created documents on “Sims, Stewart and Weis, PC” letterhead in which the accomplice, using the name “Angela Sims,” purported to be the ambassador’s financial advisor and accountant.

    The Attorney General’s office said Seck admitted he submitted false applications to other insurance companies for policies on behalf of Mansour Seck, listing Pape Michael Seck as Mansour Seck’s son and the beneficiary. However, his father, whose name is Mansour Seck, didn’t apply for the life insurance, nor did anyone by that name. In filing the applications, he also used identifying information, including a Social Security number, from two other real people named Mansour Seck, the investigation showed. One is a retired dignitary from Senegal (Mansour Seck is a common name in the country) and the other a New Jersey resident.

    Geronta agreed to rescind the policy but wanted a refund of all premiums paid. Brighthouse disagreed, so the parties took the case to Delaware Superior Court, and it later headed to the Delaware Supreme Court which was asked to determine whether premiums paid on insurance policies declared void ab initio — or having no legal effect from inception — for lack of an insurable interest should be returned.

    In the end, Pape Michael Seck’s lies caught up with him, and he was ultimately fined and sentenced to prison for the Mansour Seck case, as well as others. The legal sector is paying particular attention to the Seck decision, as it begins to offer much-needed clarity on a complex issue. While there are still unanswered questions, the case sets a precedent that will likely be followed in future litigation.

    2022 - October Life Settlement Litigation Life Settlements Longevity Risk Volume 1 Issue 6 - October 2022
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026By Fergus Bescoby

    Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

    August 6, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.